The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Major Depressive Disorder Drug-Global Market Insights and Sales Trends 2025

Major Depressive Disorder Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1813430

No of Pages : 96

Ask Your Query
Synopsis
The global Major Depressive Disorder Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Major Depressive Disorder Drug in various end use industries. The expanding demands from the Hospital, Clinic and Research Center,, are propelling Major Depressive Disorder Drug market. Aripiprazole, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the AV-101 segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Major Depressive Disorder Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Major Depressive Disorder Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Major Depressive Disorder Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Major Depressive Disorder Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Major Depressive Disorder Drug covered in this report include Bristol-Myers Squibb Company, Cerecor Inc., e-Therapeutics Plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, H. Lundbeck A/S, Hua Medicine Ltd. and Intra-Cellular Therapies, Inc., etc.
The global Major Depressive Disorder Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb Company
Cerecor Inc.
e-Therapeutics Plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
H. Lundbeck A/S
Hua Medicine Ltd.
Intra-Cellular Therapies, Inc.
Global Major Depressive Disorder Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Major Depressive Disorder Drug market, Segment by Type:
Aripiprazole
AV-101
AVP-786
Basimglurant
Brexpiprazole
Others
Global Major Depressive Disorder Drug market, by Application
Hospital
Clinic
Research Center
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Major Depressive Disorder Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Major Depressive Disorder Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Major Depressive Disorder Drug Market Overview
1.1 Major Depressive Disorder Drug Product Overview
1.2 Major Depressive Disorder Drug Market Segment by Type
1.2.1 Aripiprazole
1.2.2 AV-101
1.2.3 AVP-786
1.2.4 Basimglurant
1.2.5 Brexpiprazole
1.2.6 Others
1.3 Global Major Depressive Disorder Drug Market Size by Type
1.3.1 Global Major Depressive Disorder Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Major Depressive Disorder Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Major Depressive Disorder Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Major Depressive Disorder Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Major Depressive Disorder Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Major Depressive Disorder Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Major Depressive Disorder Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Major Depressive Disorder Drug Sales Breakdown by Type (2018-2023)
2 Global Major Depressive Disorder Drug Market Competition by Company
2.1 Global Top Players by Major Depressive Disorder Drug Sales (2018-2023)
2.2 Global Top Players by Major Depressive Disorder Drug Revenue (2018-2023)
2.3 Global Top Players by Major Depressive Disorder Drug Price (2018-2023)
2.4 Global Top Manufacturers Major Depressive Disorder Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Major Depressive Disorder Drug Market Competitive Situation and Trends
2.5.1 Major Depressive Disorder Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Major Depressive Disorder Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Major Depressive Disorder Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Major Depressive Disorder Drug Market
2.8 Key Manufacturers Major Depressive Disorder Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Major Depressive Disorder Drug Status and Outlook by Region
3.1 Global Major Depressive Disorder Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Major Depressive Disorder Drug Historic Market Size by Region
3.2.1 Global Major Depressive Disorder Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Major Depressive Disorder Drug Sales in Value by Region (2018-2023)
3.2.3 Global Major Depressive Disorder Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Major Depressive Disorder Drug Forecasted Market Size by Region
3.3.1 Global Major Depressive Disorder Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Major Depressive Disorder Drug Sales in Value by Region (2024-2029)
3.3.3 Global Major Depressive Disorder Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Major Depressive Disorder Drug by Application
4.1 Major Depressive Disorder Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Research Center
4.2 Global Major Depressive Disorder Drug Market Size by Application
4.2.1 Global Major Depressive Disorder Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Major Depressive Disorder Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Major Depressive Disorder Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Major Depressive Disorder Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Major Depressive Disorder Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Major Depressive Disorder Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Major Depressive Disorder Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Major Depressive Disorder Drug Sales Breakdown by Application (2018-2023)
5 North America Major Depressive Disorder Drug by Country
5.1 North America Major Depressive Disorder Drug Historic Market Size by Country
5.1.1 North America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Major Depressive Disorder Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Major Depressive Disorder Drug Sales in Value by Country (2018-2023)
5.2 North America Major Depressive Disorder Drug Forecasted Market Size by Country
5.2.1 North America Major Depressive Disorder Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Major Depressive Disorder Drug Sales in Value by Country (2024-2029)
6 Europe Major Depressive Disorder Drug by Country
6.1 Europe Major Depressive Disorder Drug Historic Market Size by Country
6.1.1 Europe Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Major Depressive Disorder Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Major Depressive Disorder Drug Sales in Value by Country (2018-2023)
6.2 Europe Major Depressive Disorder Drug Forecasted Market Size by Country
6.2.1 Europe Major Depressive Disorder Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Major Depressive Disorder Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Major Depressive Disorder Drug by Region
7.1 Asia-Pacific Major Depressive Disorder Drug Historic Market Size by Region
7.1.1 Asia-Pacific Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Major Depressive Disorder Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Major Depressive Disorder Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Major Depressive Disorder Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Major Depressive Disorder Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Major Depressive Disorder Drug Sales in Value by Region (2024-2029)
8 Latin America Major Depressive Disorder Drug by Country
8.1 Latin America Major Depressive Disorder Drug Historic Market Size by Country
8.1.1 Latin America Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Major Depressive Disorder Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Major Depressive Disorder Drug Sales in Value by Country (2018-2023)
8.2 Latin America Major Depressive Disorder Drug Forecasted Market Size by Country
8.2.1 Latin America Major Depressive Disorder Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Major Depressive Disorder Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Major Depressive Disorder Drug by Country
9.1 Middle East and Africa Major Depressive Disorder Drug Historic Market Size by Country
9.1.1 Middle East and Africa Major Depressive Disorder Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Major Depressive Disorder Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Major Depressive Disorder Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Major Depressive Disorder Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Major Depressive Disorder Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Major Depressive Disorder Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb Company
10.1.1 Bristol-Myers Squibb Company Company Information
10.1.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Company Major Depressive Disorder Drug Products Offered
10.1.5 Bristol-Myers Squibb Company Recent Development
10.2 Cerecor Inc.
10.2.1 Cerecor Inc. Company Information
10.2.2 Cerecor Inc. Introduction and Business Overview
10.2.3 Cerecor Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cerecor Inc. Major Depressive Disorder Drug Products Offered
10.2.5 Cerecor Inc. Recent Development
10.3 e-Therapeutics Plc
10.3.1 e-Therapeutics Plc Company Information
10.3.2 e-Therapeutics Plc Introduction and Business Overview
10.3.3 e-Therapeutics Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 e-Therapeutics Plc Major Depressive Disorder Drug Products Offered
10.3.5 e-Therapeutics Plc Recent Development
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Company Information
10.4.2 Eli Lilly and Company Introduction and Business Overview
10.4.3 Eli Lilly and Company Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly and Company Major Depressive Disorder Drug Products Offered
10.4.5 Eli Lilly and Company Recent Development
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Company Information
10.5.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 F. Hoffmann-La Roche Ltd. Major Depressive Disorder Drug Products Offered
10.5.5 F. Hoffmann-La Roche Ltd. Recent Development
10.6 GlaxoSmithKline Plc
10.6.1 GlaxoSmithKline Plc Company Information
10.6.2 GlaxoSmithKline Plc Introduction and Business Overview
10.6.3 GlaxoSmithKline Plc Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Plc Major Depressive Disorder Drug Products Offered
10.6.5 GlaxoSmithKline Plc Recent Development
10.7 H. Lundbeck A/S
10.7.1 H. Lundbeck A/S Company Information
10.7.2 H. Lundbeck A/S Introduction and Business Overview
10.7.3 H. Lundbeck A/S Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 H. Lundbeck A/S Major Depressive Disorder Drug Products Offered
10.7.5 H. Lundbeck A/S Recent Development
10.8 Hua Medicine Ltd.
10.8.1 Hua Medicine Ltd. Company Information
10.8.2 Hua Medicine Ltd. Introduction and Business Overview
10.8.3 Hua Medicine Ltd. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hua Medicine Ltd. Major Depressive Disorder Drug Products Offered
10.8.5 Hua Medicine Ltd. Recent Development
10.9 Intra-Cellular Therapies, Inc.
10.9.1 Intra-Cellular Therapies, Inc. Company Information
10.9.2 Intra-Cellular Therapies, Inc. Introduction and Business Overview
10.9.3 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Intra-Cellular Therapies, Inc. Major Depressive Disorder Drug Products Offered
10.9.5 Intra-Cellular Therapies, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Major Depressive Disorder Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Major Depressive Disorder Drug Industrial Chain Analysis
11.4 Major Depressive Disorder Drug Market Dynamics
11.4.1 Major Depressive Disorder Drug Industry Trends
11.4.2 Major Depressive Disorder Drug Market Drivers
11.4.3 Major Depressive Disorder Drug Market Challenges
11.4.4 Major Depressive Disorder Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Major Depressive Disorder Drug Distributors
12.3 Major Depressive Disorder Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock